increased sarcoma incidence_Cdkn2a<tm2.1Brn>/Cdkn2a<tm2.1Brn>

http://metadb.riken.jp/0002032I129P2OlaHsdFVBNCdkn2atm21BrnCdkn2atm21BrnCdkn2atm21Brn

increased sarcoma incidence_Cdkn2a<tm2.1Brn>/Cdkn2a<tm2.1Brn>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cyclin-dependent kinase inhibitor 2A
  http://metadb.riken.jp/db/mgi_rdf/MGI:104738

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdkn2a<tm2.1Brn>/Cdkn2a<tm2.1Brn>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdkn2a<tm2.1Brn>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased sarcoma incidence
  http://purl.obolibrary.org/obo/MP_0002032

文献

http://purl.org/net/cito/citesAsAuthority

• P. Krimpenfort, et.al., Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice., Nature, 2001, 413
  http://rdf.ncbi.nlm.nih.gov/pubmed/11544530